These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17958544)

  • 21. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
    Hegde U; Chhabra A; Chattopadhyay S; Das R; Ray S; Chakraborty NG
    Pathobiology; 2008; 75(3):200-8. PubMed ID: 18550918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
    Forsberg O; Carlsson B; Malmström PU; Ullenhag G; Tötterman TH; Essand M
    Prostate; 2009 Jan; 69(1):70-81. PubMed ID: 18814178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
    Eiz-Vesper B; Horn PA; Daubert C; Khattab B; Blasczyk R
    Transfusion; 2006 Jul; 46(7):1210-20. PubMed ID: 16836569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of human cytomegalovirus-specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system.
    Charpentier B; Michelson S; Martin B
    J Immunol; 1986 Jul; 137(1):330-6. PubMed ID: 2423608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies.
    Hasan AN; Selvakumar A; Doubrovina E; Riviere I; Sadelain MW; O'Reilly RJ
    Discov Med; 2009 Dec; 8(43):210-8. PubMed ID: 20040272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library.
    Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G
    Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated B cells mediate efficient expansion of rare antigen-specific T cells.
    Zentz C; Wiesner M; Man S; Frankenberger B; Wollenberg B; Hillemanns P; Zeidler R; Hammerschmidt W; Moosmann A
    Hum Immunol; 2007 Feb; 68(2):75-85. PubMed ID: 17321896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.
    Latouche JB; Sadelain M
    Nat Biotechnol; 2000 Apr; 18(4):405-9. PubMed ID: 10748520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
    Yao J; Bechter C; Wiesneth M; Härter G; Götz M; Germeroth L; Guillaume P; Hasan F; von Harsdorf S; Mertens T; Michel D; Döhner H; Bunjes D; Schmitt M; Schmitt A
    Clin Infect Dis; 2008 May; 46(10):e96-105. PubMed ID: 18419478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy.
    Zandvliet ML; Falkenburg JH; Jedema I; Willemze R; Guchelaar HJ; Meij P
    J Immunother; 2009 Jun; 32(5):513-23. PubMed ID: 19609244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
    Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
    J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct ex vivo detection of HLA-DR3-restricted cytomegalovirus- and Mycobacterium tuberculosis-specific CD4+ T cells.
    Bronke C; Palmer NM; Westerlaken GH; Toebes M; van Schijndel GM; Purwaha V; van Meijgaarden KE; Schumacher TN; van Baarle D; Tesselaar K; Geluk A
    Hum Immunol; 2005 Sep; 66(9):950-61. PubMed ID: 16360834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device.
    Perseghin P; D'Amico G; Dander E; Gaipa G; Dassi M; Biagi E; Biondi A
    Transfusion; 2008 Aug; 48(8):1644-9. PubMed ID: 18513258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective binding of CD4 and CD8 T-cells to antigen presenting cells for enrichment of CMV and HIV specific T-lymphocytes.
    Li Pira G; Ivaldi F; Manca F
    J Immunol Methods; 2012 Feb; 376(1-2):125-31. PubMed ID: 22251662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus-specific human CD4 and CD8 T lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Risso M; Tripodi G; Manca F
    Transfusion; 2006 Dec; 46(12):2053-62. PubMed ID: 17176316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
    Lim JB; Provenzano M; Kwon OH; Bettinotti M; Caruccio L; Nagorsen D; Stroncek D
    Exp Hematol; 2006 Mar; 34(3):296-307. PubMed ID: 16543064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA Tetramer Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma.
    Jiang X; Lu X; Liu R; Zhang F; Zhao H
    Clin Cancer Res; 2007 Dec; 13(24):7329-34. PubMed ID: 18094414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.